Study Details
Design, interventions, and primary outcomes
About This Study
This trial is to investigate if in patients with clinically node positive breast cancer undergoing upfront surgery, treatment with TAS and ART is superior to ALND in terms of arm-related Quality of Life (QoL) and occurrence of lymphedema two years after randomization.
Design
Interventions / Regimen
- Procedure: Axillary lymph node dissection (ALND) — Surgical removal of lymphatic tissue within the anatomical boundaries of the axilla (standard of care in the upfront surgery setting in patients with cN+ BC)
- Procedure: Axillary radiotherapy (ART) — Axillary irradiation
Primary Outcomes
- Change in arm-related Quality of Life (QoL) (From baseline to 2 years after randomization)
- Occurrence of lymphedema (From baseline to 2 years after randomization)
Phase: NA
Status: Recruiting
Start Date: 2026-01-01
Completion: 2037-12
Sex: ALL
Volunteers: false
Enrollment: 1060 (ESTIMATED)
- Walter P. Weber, Prof. Dr. med. (PRINCIPAL_INVESTIGATOR) - Breast Surgery Service, University Hospital Basel
- Procedure: Axillary lymph node dissection (ALND) — Surgical removal of lymphatic tissue within the anatomical boundaries of the axilla (standard of care in the upfront surgery setting in patients with cN+ BC)
- Procedure: Axillary radiotherapy (ART) — Axillary irradiation